A: Recombinant DNA technology is less effecti | vedclass

Name: Exam Paper Generator | JEE NEET Paper Generator | Vedclass
Brand: Vedclass
Rating: 5 (35 reviews)

Question

(D) The Assertion is incorrect because recombinant $DNA$ technology has been highly effective in producing therapeutic drugs,such as human insulin. Th

Vedclass · Accepted Answer

Both Assertion and Reason are incorrect.

Vedclass · Answer

(D) The Assertion is incorrect because recombinant $DNA$ technology has been highly effective in producing therapeutic drugs,such as human insulin. The Reason is also incorrect because recombinant therapeutics are designed to be identical to human proteins,thereby minimizing or preventing unwanted immunological responses that were common with non-human derived therapeutics. Therefore,both the Assertion and the Reason are incorrect.

$A$: Recombinant $DNA$ technology is less effective in therapeutic drug production.
$R$: Recombinant therapeutics induce unwanted immunological responses.

Similar Questions

Which microorganisms are commonly used to produce vaccines through recombinant $DNA$ technology?

Which human medicine was the first to be produced using recombinant $DNA$ technology?

Adenosine deaminase $(ADA)$ deficiency is most commonly caused by which genetic abnormality?

Which of the following is commonly used as a vector for introducing a $DNA$ fragment in human lymphocytes?

The first clinical gene therapy was given for treating

Vedclass Test Series

Exam Paper Generator

Online Exam Module

$A$: Recombinant $DNA$ technology is less effective in therapeutic drug production.$R$: Recombinant therapeutics induce unwanted immunological responses.